Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.68x is 68% above its 4-year average of -5.29x, near the high end of its 4-year range (-212.51x–-0.70x).
12.27% above its 12-month average of -1.91x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.50x.
INTEREST COVERAGE RATIO
-1.68x
INTEREST COVERAGE RATIO AVG TTM
-1.91x
INTEREST COVERAGE RATIO AVG 3Y
-3.34x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+12.27%
CURRENT VS 3Y AVG
+49.69%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+70.98%
vs the sector median at left
QT Imaging Holdings, Inc.
Market Cap
$35.42M
Interest Coverage Ratio
-1.68x
TTM Avg
-1.91x
3Y Avg
-3.34x
5Y Avg
N/A
Market Cap
$35.80M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$37.08M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.76M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$34.97M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$37.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$34.11M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | $35.42M | -1.68x | -1.91x | -3.34x | N/A |
| DocGo Inc. (DCGO)vs › | $35.80M | -87.92x | 13.24x | 16.68x | 16.68x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.08M | -33.29x | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.60M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.76M | 47.58x | 47.58x | 47.58x | 47.58x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -735.69x | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $37.71M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.11M | -0.75x | 0.33x | 0.47x | 0.65x |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | -0.13x | 0.53x | 0.64x | 0.43x |
Interest Coverage
-1.7x
Debt/Equity
1.93
Current Ratio
3.10
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.50x |
| 2026-03-31 | -0.70x |
| 2025-12-31 | -0.70x |
| 2025-09-30 | -2.93x |
| 2025-06-30 | -2.75x |
| 2025-03-31 | -1.51x |
| 2024-12-31 | -1.52x |
| 2024-09-30 | -1.60x |
| 2024-06-30 | -2.03x |
| 2024-03-31 | -9.31x |
| 2023-12-31 | -5.42x |
| 2023-09-30 | -20.52x |
| 2023-06-30 | -9.11x |
| 2023-03-31 | -13.45x |
| 2022-12-31 | -88.80x |
| 2022-09-30 | -212.51x |
